Fluorescent intensity assay for protein or peptide binding to nucleic acids
AssigneeIngeneus Corporation
InventorsJasmine I. Daksis, Glen H. Erikson
Life of this patent
Estimating the term…
Loading patent…
AssigneeIngeneus Corporation
InventorsJasmine I. Daksis, Glen H. Erikson
Estimating the term…
A method for assaying binding between a fluorophore-labeled compound and an unlabeled compound is provided. The method includes detecting a quenching effect on fluorescence emitted by the fluorophore-labeled compound resulting from binding. The binding is specific and other than nucleobase to nucleobase. The method is conducted without separating complexes of the fluorophore-labeled compound and the unlabeled compound from the fluorophore-labeled compound prior to quenching effect detecting, and without providing a signal quenching agent to quench fluorescent light. Preferably, the fluorophore-labeled compound is a nucleic acid and the unlabeled compound is a protein. The method can be used for a variety of applications, including screening for drug candidates having optimum binding properties, and quantifying the binding affinity of DNA binding proteins for nucleic acids.
A method for assaying binding between at least one fluorophore-labeled compound and at least one unlabeled compound, said method comprising detecting a quenching effect on fluorescence emitted by said at least one fluorophore-labeled compound resulting from said binding, said quenching effect detecting comprising:
Dependencies are inferred from the claim text.